Position
Prostatis Group LLC in Thermo Fisher Scientific Inc.
Back to the book · All holders of TMO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$235.8K$579.50 → $491.46
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 2.68K | $1.55M | — | — | — | 0.4% |
| Q1 2026 | 2.81K | $1.38M | $491.46 | −$235.8K | $66.8K | 0.4% |